Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001385374-15-000002
Filing Date
2015-12-30
Accepted
2015-12-30 15:39:08
Documents
1
Effectiveness Date
2015-12-30
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8616
  Complete submission text file 0001385374-15-000002.txt   9712
Mailing Address 500 BOYLSTON STREET, SUITE 1600 boston ma 02116
Business Address 500 BOYLSTON STREET, SUITE 1600 boston ma 02116 617-482-2333
Gelesis Inc (Filer) CIK: 0001385374 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-254182 | Film No.: 151313497
SIC: 2834 Pharmaceutical Preparations